Mylan Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS LTD, and what generic and branded alternatives to MYLAN LABS LTD drugs are available?
MYLAN LABS LTD has one hundred and forty-seven approved drugs.
There are nine tentative approvals on MYLAN LABS LTD drugs.
Drugs and US Patents for Mylan Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | CISPLATIN | cisplatin | INJECTABLE;INJECTION | 091062-001 | Apr 18, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 203258-001 | Jul 20, 2018 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Labs Ltd | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 202742-001 | Oct 30, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.